Yip Hon Chi, Uedo Noriya, Chan Shannon M, Teoh Anthony Yuen Bun, Wong Simon Kin Hung, Chiu Philip W, Ng Enders Kwok Wai
Division of Upper GI and Metabolic Surgery, Department of Surgery, Prince of Wales Hospital, the Chinese University of Hong Kong, Hong Kong.
Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan.
Endosc Int Open. 2020 Oct;8(10):E1365-E1370. doi: 10.1055/a-1230-3586. Epub 2020 Sep 22.
Atrophic gastritis (AG) and intestinal metaplasia (IM) are premalignant conditions of gastric cancer and endoscopic recognition and characterization may help in stratifying the gastric cancer risk for screening and surveillance. However, there is currently lack of consensus in defining the severity of AG and IM. We aimed to conduct an international survey to understand the current practice of endoscopists worldwide. An online survey was designed to collect data regarding participants' practice in endoscopic assessment of AG & IM. A test using images was conducted to evaluate the difference in accuracy of characterization of AG & IM. From July to October 2017, 249 endoscopists responded to the survey. Around 70 % of participants received some form of training on recognition of AG & IM. There was significant variety in the training received across different continents. One hundred seventy-six participants (70 %) would document the presence of both AG and IM, but the classification systems used were inconsistent between endoscopists. Overall accuracy in diagnosis of AG & IM in the image test was 84.5 % and 80.7 % respectively. The diagnostic accuracy was significantly higher among Japanese and Korean endoscopists compared to the rest of the world. Training regarding endoscopic recognition of AG & IM differs significantly in different parts of the world. The difference in diagnostic accuracy for these premalignant gastric conditions may also explain the discrepancy in the early cancer detection rates among different countries. A simple unified classification system may be beneficial for better stratification of cancer risks.
萎缩性胃炎(AG)和肠化生(IM)是胃癌的癌前病变,内镜识别和特征描述有助于对胃癌风险进行分层,以用于筛查和监测。然而,目前在定义AG和IM的严重程度方面缺乏共识。我们旨在进行一项国际调查,以了解全球内镜医师的当前实践情况。设计了一项在线调查,以收集有关参与者对AG和IM进行内镜评估的实践数据。进行了一项使用图像的测试,以评估AG和IM特征描述准确性的差异。2017年7月至10月,249名内镜医师回复了该调查。约70%的参与者接受了某种形式的AG和IM识别培训。不同大洲接受的培训存在显著差异。176名参与者(70%)会记录AG和IM的存在,但内镜医师使用的分类系统不一致。图像测试中AG和IM诊断的总体准确率分别为84.5%和80.7%。与世界其他地区相比,日本和韩国内镜医师的诊断准确率显著更高。世界各地关于AG和IM内镜识别的培训差异很大。这些胃癌前病变诊断准确性的差异也可能解释了不同国家早期癌症检出率的差异。一个简单统一的分类系统可能有利于更好地对癌症风险进行分层。